> Your comparison of your friends in Germany vs "insanity" in the US doesn't feel relevant
It's incredibly relevant, why are GLP-1s less needed in Germany vs. US (and other countries like Canada)? This is the insanity they are talking about, not the users of the medication.
Couple that with a very car centric lifestyle and yea. Its not great.
Aside from whether the local healthcare coverage will pay for it, and the rate of GLP1 usage probably being proportional to the obesity rate, what is the basis for assuming there is disproportionately fewer people in Germany using these medications? Most people don't announce it.
I'd love to hear any sort of actual facts backing that claim. It sounds truthy.